Dynamic Metabolic Response to Adriamycin-Induced Senescence in Breast Cancer Cells
Cellular senescence displays a heterogeneous set of phenotypes linked to tumor suppression; however, after drug treatment, senescence may also be involved in stable or recurrent cancer. Metabolic changes during senescence can provide detailed information on cellular status and may also have implicat...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2018-12-01
|
| Series: | Metabolites |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2218-1989/8/4/95 |
| _version_ | 1831794842515013632 |
|---|---|
| author | Rong You Jin Dai Ping Zhang Gregory A. Barding Daniel Raftery |
| author_facet | Rong You Jin Dai Ping Zhang Gregory A. Barding Daniel Raftery |
| author_sort | Rong You |
| collection | DOAJ |
| description | Cellular senescence displays a heterogeneous set of phenotypes linked to tumor suppression; however, after drug treatment, senescence may also be involved in stable or recurrent cancer. Metabolic changes during senescence can provide detailed information on cellular status and may also have implications for the development of effective treatment strategies. The metabolic response to Adriamycin (ADR) treatment, which causes senescence as well as cell death, was obtained with the aid of metabolic profiling and isotope tracing in two human breast cancer cell lines, MCF7 and MDA-MB-231. After 5 days of ADR treatment, more than 60% of remaining, intact cells entered into a senescent state, characterized by enlarged and flattened morphology and positive blue staining using SA-β-gal. Metabolic trajectory analysis showed that the two cell lines’ responses were significantly different and were divided into two distinct stages. The metabolic shift from the first stage to the second was reflected by a partial recovery of the TCA cycle, as well as amino acid and lipid metabolisms. Isotope tracing analysis indicated that the higher level of glutamine metabolism helped maintain senescence. The results suggest that the dynamic changes during senescence indicate a multi-step process involving important metabolic pathways which might allow breast cancer cells to adapt to persistent ADR treatment, while the higher level of anapleurosis may be important for maintaining the senescent state. Ultimately, a better understanding of metabolic changes during senescence might provide targets for cancer therapy and tumor eradication. |
| first_indexed | 2024-12-22T15:57:44Z |
| format | Article |
| id | doaj.art-684a6efefb2f4d8f9fc54328b1b7a2f3 |
| institution | Directory Open Access Journal |
| issn | 2218-1989 |
| language | English |
| last_indexed | 2024-12-22T15:57:44Z |
| publishDate | 2018-12-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Metabolites |
| spelling | doaj.art-684a6efefb2f4d8f9fc54328b1b7a2f32022-12-21T18:20:44ZengMDPI AGMetabolites2218-19892018-12-01849510.3390/metabo8040095metabo8040095Dynamic Metabolic Response to Adriamycin-Induced Senescence in Breast Cancer CellsRong You0Jin Dai1Ping Zhang2Gregory A. Barding3Daniel Raftery4College of Life Sciences, South China Normal University, 55 Zhongshan Avenue West, Guangzhou 510631, ChinaMitochondria and Metabolism Center, Department of Anesthesiology and Pain Medicine, University of Washington, 850 Republican Street, Seattle, WA 98109, USAMitochondria and Metabolism Center, Department of Anesthesiology and Pain Medicine, University of Washington, 850 Republican Street, Seattle, WA 98109, USAMitochondria and Metabolism Center, Department of Anesthesiology and Pain Medicine, University of Washington, 850 Republican Street, Seattle, WA 98109, USAMitochondria and Metabolism Center, Department of Anesthesiology and Pain Medicine, University of Washington, 850 Republican Street, Seattle, WA 98109, USACellular senescence displays a heterogeneous set of phenotypes linked to tumor suppression; however, after drug treatment, senescence may also be involved in stable or recurrent cancer. Metabolic changes during senescence can provide detailed information on cellular status and may also have implications for the development of effective treatment strategies. The metabolic response to Adriamycin (ADR) treatment, which causes senescence as well as cell death, was obtained with the aid of metabolic profiling and isotope tracing in two human breast cancer cell lines, MCF7 and MDA-MB-231. After 5 days of ADR treatment, more than 60% of remaining, intact cells entered into a senescent state, characterized by enlarged and flattened morphology and positive blue staining using SA-β-gal. Metabolic trajectory analysis showed that the two cell lines’ responses were significantly different and were divided into two distinct stages. The metabolic shift from the first stage to the second was reflected by a partial recovery of the TCA cycle, as well as amino acid and lipid metabolisms. Isotope tracing analysis indicated that the higher level of glutamine metabolism helped maintain senescence. The results suggest that the dynamic changes during senescence indicate a multi-step process involving important metabolic pathways which might allow breast cancer cells to adapt to persistent ADR treatment, while the higher level of anapleurosis may be important for maintaining the senescent state. Ultimately, a better understanding of metabolic changes during senescence might provide targets for cancer therapy and tumor eradication.https://www.mdpi.com/2218-1989/8/4/95senescence MCF7MDA-MB-231metabolomicsisotope tracing analysisgas chromatography–mass spectrometry (GC–MS) |
| spellingShingle | Rong You Jin Dai Ping Zhang Gregory A. Barding Daniel Raftery Dynamic Metabolic Response to Adriamycin-Induced Senescence in Breast Cancer Cells Metabolites senescence MCF7 MDA-MB-231 metabolomics isotope tracing analysis gas chromatography–mass spectrometry (GC–MS) |
| title | Dynamic Metabolic Response to Adriamycin-Induced Senescence in Breast Cancer Cells |
| title_full | Dynamic Metabolic Response to Adriamycin-Induced Senescence in Breast Cancer Cells |
| title_fullStr | Dynamic Metabolic Response to Adriamycin-Induced Senescence in Breast Cancer Cells |
| title_full_unstemmed | Dynamic Metabolic Response to Adriamycin-Induced Senescence in Breast Cancer Cells |
| title_short | Dynamic Metabolic Response to Adriamycin-Induced Senescence in Breast Cancer Cells |
| title_sort | dynamic metabolic response to adriamycin induced senescence in breast cancer cells |
| topic | senescence MCF7 MDA-MB-231 metabolomics isotope tracing analysis gas chromatography–mass spectrometry (GC–MS) |
| url | https://www.mdpi.com/2218-1989/8/4/95 |
| work_keys_str_mv | AT rongyou dynamicmetabolicresponsetoadriamycininducedsenescenceinbreastcancercells AT jindai dynamicmetabolicresponsetoadriamycininducedsenescenceinbreastcancercells AT pingzhang dynamicmetabolicresponsetoadriamycininducedsenescenceinbreastcancercells AT gregoryabarding dynamicmetabolicresponsetoadriamycininducedsenescenceinbreastcancercells AT danielraftery dynamicmetabolicresponsetoadriamycininducedsenescenceinbreastcancercells |